NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALSJosé Jiménez-Villegas, Ana I. Rojo|Free Radical Biology and Medicine|2021Cited by 43
Dipeptide Repeat Pathology in C9orf72-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway ImbalanceJosé Jiménez-Villegas, Ana I. Rojo|Antioxidants|2022Cited by 17